Mahesh V. Madhavan, MD, MS (@mvmadhavanmd) 's Twitter Profile
Mahesh V. Madhavan, MD, MS

@mvmadhavanmd

Structural Interventional Cardiologist and Clinical Investigator @columbiacardio | @nypcucvi | @nyphospital | @garnethealth | @crfheart. Tweets are my own.

ID: 1190460590

linkhttps://www.columbiacardiology.org/profile/mahesh-v-madhavan-md calendar_today17-02-2013 17:46:43

561 Tweet

1,1K Followers

716 Following

Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

Another fantastic day at #TVT2023 filled with outstanding education, training, and networking opportunities! See you tomorrow for more late-breaking clinical science, live cases, and spotlight sessions! #CardioEd #CardioResearch

Another fantastic day at #TVT2023 filled with outstanding education, training, and networking opportunities! See you tomorrow for more late-breaking clinical science, live cases, and spotlight sessions! #CardioEd #CardioResearch
JACC Journals (@jaccjournals) 's Twitter Profile Photo

New data from the #COAPT trial! How does malnutrition affect outcomes in pts w/ #heartfailure & secondary mitral regurgitation? Does #TEER impact outcomes? Read more from Drs. Andrea Scotti, Gregg W. Stone MD, & colleagues to find out: bit.ly/42s5zdX #JACC #vhdMR

New data from the #COAPT trial!

How does malnutrition affect outcomes in pts w/ #heartfailure &amp; secondary mitral regurgitation? Does #TEER impact outcomes? Read more from Drs. <a href="/AndreaScotti21/">Andrea Scotti</a>, <a href="/GreggWStone/">Gregg W. Stone MD</a>, &amp; colleagues to find out: bit.ly/42s5zdX

#JACC #vhdMR
Mahesh V. Madhavan, MD, MS (@mvmadhavanmd) 's Twitter Profile Photo

Illustrative case images (with angios and intravascular imaging) on re-protruding calcium nodules after #PCI with #DES in JACC Journals. Thanks to @ajaykirtane Akiko Maehara Marissa Alsaloum Margaret McEntegart Megha Prasad MD MS! @NYPCUCVI Cardiovascular Research Foundation tinyurl.com/mwmb8hjv

RTHahnMD (@hahn_rt) 's Twitter Profile Photo

ALL DAY TODAY! Do not miss the First Ever #TCT2023 M-TEER Training for BOTH MitraClip and PASCAL!! TCTMD TCT Conference Preregister and Attend: tct2023.crfconnect.com/simulated-spin…

Dan Snyder, MD (@dansnyder01) 's Twitter Profile Photo

Great abstract session this morning at #CTO2024 moderated by David J. Cohen, MD, MSc! Appreciated the opportunity to present our teams work on the utility of platelet function testing following complex PCI for patients on therapeutic AC Mahesh V. Madhavan, MD, MS Dr. Jeffrey W. Moses

Great abstract session this morning at #CTO2024 moderated by <a href="/djc795/">David J. Cohen, MD, MSc</a>! Appreciated the opportunity to present our teams work on the utility of platelet function testing following complex PCI for patients on therapeutic AC <a href="/MVMadhavanMD/">Mahesh V. Madhavan, MD, MS</a> <a href="/JWMoses/">Dr. Jeffrey W. Moses</a>
Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

🌟 Dr. Martin Leon introduces #NYValves2024 – the definitive meeting in valvular heart disease! 🌟 🗽 Join us in NYC for an exciting educational experience where the power of #HeartTeam collaboration takes center stage. 💪 From transcatheter valve therapy and imaging to surgical

Dr. Gilbert Tang (@gilberttangmd) 's Twitter Profile Photo

Congrats Mateo Marín-Cuartas Syed Zaid, MD et al for the CUTTING-EDGE failed M-TEER registry MV repair vs replacement JUST OUT JACC Journals #JACCINT! Most MV gets replaced with worse outcomes. Will see how REPAIR-MR and PRIMARY trial play out down the road! jacc.org/doi/full/10.10…

Congrats <a href="/MMarinCuartas/">Mateo Marín-Cuartas</a> <a href="/SyedZaidMD/">Syed Zaid, MD</a> et al for the CUTTING-EDGE failed M-TEER registry MV repair vs replacement JUST OUT <a href="/JACCJournals/">JACC Journals</a> #JACCINT! Most MV gets replaced with worse outcomes. Will see how REPAIR-MR and PRIMARY trial play out down the road!
jacc.org/doi/full/10.10…
Structural Heart (@crfshj) 's Twitter Profile Photo

📊 Real-world analysis: At 3 years, pts w/severe TR faced high rates of death, adverse events, & significant healthcare costs. More long-term data needed to evaluate the value of transcatheter therapies. ow.ly/5Yq450W0Ve3 Mahesh V. Madhavan, MD, MS Barker David J. Cohen, MD, MSc Jeffrey Popma

📊 Real-world analysis: At 3 years, pts w/severe TR faced high rates of death, adverse events, &amp; significant healthcare costs. More long-term data needed to evaluate the value of transcatheter therapies. ow.ly/5Yq450W0Ve3 <a href="/MVMadhavanMD/">Mahesh V. Madhavan, MD, MS</a> <a href="/colinbarkerMD/">Barker</a> <a href="/djc795/">David J. Cohen, MD, MSc</a> <a href="/PopmaJeffrey/">Jeffrey Popma</a>